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Abstract 
The TKS5 protein, encoded by the gene 
SH3PXD2A, is a scaffolding protein essential for the 
formation of podosomes and invadopodia in 
untransformed cells and cancer cells, respectively. 
Podosomes and invadopodia (which collectively are 
termed invadosomes) are actin-rich cellular 
protrusions capable of secreting proteolytic enzymes 
that can degrade the extracellular matrix. These 
structures are thought to regulate cellular migration 
and invasion, as well as adhesion and the release of 
growth factors. In the context of cancer, TKS5-
dependent invadopodia activity has been shown to 
play important roles in tumor growth and metastasis 
in various cancer types. Multiple isoforms of TKS5 
exist due to alternative mRNA splicing and promoter 
usage. 
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Identity 
Other names: TKS5, FISH, SH3MD1, KIAA0418 
HGNC (Hugo): SH3PXD2A 
Location: 10q24.33 
DNA/RNA 
Description 
The SH3PXD2A gene is located on chromosome 10 
(10q24.33). It contains 15 exons. 
Transcription 
The full-length SH3PXD2A transcript is 11264 nt in 
length. Multiple TKS5 isoforms arise as a result of 
alternative mRNA splicing involving exons 7 and 
10, and alternative use of transcription start sites. 
Protein 
Description 
The full-length SH3PXD2A transcript (TKS5-
LONG or TKS5-ALPHA) is transcribed from a 
promoter upstream of exon 1 and is translated into a 
150 kDa protein that contains a Phox-homology 
(PX) domain in the N-terminus and five Src 
homology 3 (SH3) domains in the C-terminus. The 
shorter isoforms that arise from downstream 
transcription start sites lack the PX domain but retain 
the five SH3 domains. Because the PX domain is 
required for binding to the cell membrane, full-
length TKS5 is able to localize to invadosome foci 
but the short isoforms cannot. 
Expression 
TKS5 expression is detected in many tissue types, 
including brain, lung, liver, heart, skeletal muscles, 
and, kidneys, but was low in spleen and absent in 
testis (Lock et al, 1998). Tks5 has also been detected 
in many cell types, including macrophages, 
myoblasts, neural crest cells, osteoblasts, and 
neurons (Burger et al., 2011; Thompson et al., 2008; 
Murphy et al., 2011; Oikawa et al., 2012; Santiago-
Medina et al. 2015). 
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The SH3PXD2A locus encodes multiple TKS5 isoforms as a result of alternative splicing at exons 7 and 10 as well as alternative 
promoter usage. Genomic information was obtained from the UCSC genome browser (http://genome.ucsc.edu/). Short-form 
Tks5 (Tks5-short and Tks5-beta) have been reported by Li et al. (2013) and Cejudo-Martin et al. (2014). 
 
 
Localisation 
Cytoplasmic and at invadosome foci. 
Function 
TKS5 was initially identified as a substrate for SRC 
(Lock et al., 1998), and was subsequently shown to 
play a critical role in invadosome formation in 
multiple cell types (Courtneidge, 2011; Murphy and 
Courtneidge, 2011; Paz et al., 2013). 
Full-length TKS5 functions as an adaptor for 
recruiting other proteins to the cell membrane for 
invadosome formation.  
The recruitment of TKS5 to the cell membrane 
depends on its PX domain and phosphorylation by 
Src (Abram et al., 2003). It has been proposed that 
phosphorylation of TKS5 releases its PX domain 
from intramolecular interaction and allows TKS5 to 
bind to cell membrane phosphatidylinositol lipids, 
such as phosphatidylinositol-3,4-bisphosphate 
(PI(3,4)P2) (Abram et al., 2003; Oikawa et al.,  
2008). At the cell membrane, TKS5 is thought to 
interact with multiple components of invadosomes 
either directly or indirectly, and thereby mediates 
invadosome formation and maturation (Sharma et 
al., 2013). These interacting partners includes 
adaptor proteins and actin regulatory proteins, such 
as NCK1, NCK2, GRB2, CTTN (Cortactin), WASL 
(N-WASP), ACTR2/ACTR3 (Arp2/3) complex, and 
ARHGAP35 (p190RhoGAP) (Crimaldi et al., 2009; 
Oikawa et al., 2008; Stylli et al., 2009). TKS5 also 
interacts with NOXA1 and CYBA (p22phox), which 
are components of the NADPH oxidase complex, 
and thereby promotes reactive oxygen species (ROS) 
production by NOX enzymes at invadosomes (Diaz 
et al., 2009; Gianni et al., 2010; 2009). ROS have 
been shown to facilitate invadosome formation by 
maintaining or amplifying the phosphorylation of 
TKS5. As such, TKS5 is thought to promote 
invadosome formation via ROS in a positive 
feedback loop. 
 
The full-length TKS5 mRNA encodes a protein that contains a PX domain and five SH3 domains, as well as proline-rich regions 
(PxxP) and Src phosphorylation sites (Y). The various short isoforms lack the PX domain. 
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Finally, TKS5 has also been shown to interact with 
members of the ADAM family metalloproteases, 
specifically ADAM12, ADAM15, ADAM19 
(Abram et al., 2003). It is believed that Tks5 recruits 
theses proteases to the invadosome foci for 
processing growth factors and regulating cell 
motility. For example, ADAM12 has been shown to 
promote ectodomain shedding of HBEGF (heparin-
binding EGF-like growth factor) and enhance 
invadopodia formation in cancer cells (Diaz et al., 
2013). 
In the context of cancer, TKS5-dependent formation 
of invadopodia is thought to promote metastasis by 
mediating local tumor invasion and intravasation at 
the primary site, as well as extravasation and 
colonization at the distant site (Murphy and 
Courtneidge, 2011; Paz et al., 2014). 
In the context of normal development, TKS5-
depedent podosomes are important for mediating 
cell migration during embryogenesis. Knockdown of 
Tks5 in zebrafish led to impaired dorsal-ventral 
migration of neural crest cells and defective 
craniofacial structures and pigmentation (Murphy et 
al., 2011). Similarly, genetic deletion of Tks5 in 
mice led to complete cleft of the secondary palate 
and neonatal death (Cejudo-Martin et al., 2014). In 
addition, study in Xenopus showed that Tks5-
dependent podosomes are also required for the 
migration of neuronal growth cones (Santiago-
Medina et al., 2015). 
While most studies have focused on full-length 
TKS5, shorter isoforms of TKS5 that lack the PX 
domain have been reported (Lock et al, 1998; Li et 
al., 2013; Cejudo-Martin et al., 2014).  
There are few reports on the functions of these short 
isoforms.  
Experiments in mouse lung cancer cell lines showed 
that overexpression of a short isoform (Tks5-short) 
suppressed invadopodia function by disrupting the 
stability of invadopodia (Li et al., 2013). In addition, 
overexpression of a short-form equivalent protein, 
ΔPX-Tks5, in Xenopus neural crest cells inhibited 
invadosome functions and impaired motoneuron 
axon extension into the peripheral myotomal tissue 
in Xenopus embryos (Santiago-Medina et al., 2015). 
These data suggest that the short forms of TKS5 can 
function as negative regulators of invadosomes. 
At the mRNA level, the transcription of full-length 
Tks5 has been shown to be synergistically inhibited 
by the developmental regulators NKX2-1, FOXA2, 
and CDX2 in lung adenocarcinoma (Li et al., 2015).  
Furthermore, TKS5 has been shown to be a target of 
the microRNA mir200-c (Sundararajan et al., 2015). 
In terms of protein stability and abundance, the full-
length isoform of TKS5 is positively  
regulated by Src, while the short isoform (TKS5-
beta) is negatively regulated by Src (Cejudo-Martin 
et al. 2014). 
Homology 
TKS5 is homologous to SH3PXD2B (TKS4), 
another adaptor protein that functions as a Src 
substrate and promotes invadosome function 
(Buschman et al, 2009). TKS4 contains a PX domain 
at the N-terminus and four SH3 domains in the C-
terminus. 
Implicated in 
Breast cancer 
TKS5 expression is increased in human primary 
breast tumors compared to normal tissues, and is 
further increased in metastases (Stylli et al., 2014). 
TKS5 is required for invadopodia formation in 
breast cancer cells (Seals et al, 2005).  
TKS5-dependent invadopodia have been shown to 
promote tumor growth in a transplantation setting, 
cancer cell intravasation and extravasation, and 
metastasis formation (Eckert et al., 2011; 
Gligorijevic et al., 2012; Leong et al., 2014; Blouw 
et al., 2015).  
Expression of full-length TKS5 in human breast 
tumors correlated with poor prognosis (Blouw et al., 
2015). 
Lung cancer 
TKS5 expression is increased in human lung tumors 
compared to normal tissues (Stylli et al., 2014). Full-
length Tks5 is required for metastasis in a mouse 
model of lung cancer (Li et al., 2013). Furthermore, 
higher expression of full-length TKKS5 relative to 
short-form TKS5 correlated with poor survival of 
early-stage lung adenocarcinoma patients (Li et al., 
2013). 
Melanoma 
TKS5 is required for invadopodia formation in 
melanoma cells (Seals et al, 2005). 
Prostate cancer 
TKS5 expression is increased in human prostate 
tumors compared to normal tissues, and is required 
for invadopodia function in prostate cancer cells 
(Stylli et al., 2014; Burger et al., 2014). 
Gliomas 
TKS5 expression correlates with poor survival of 
glioma patients (Stylli et al., 2011). 
Colon Cancer 
TKS5 expression is increased in human colon 
tumors compared to normal tissues (Stylli et al., 
2014). 
Alzeimer disease 
KS5 and ADAM12 have been proposed to mediate 
the toxicity of amyloid-β peptide (Aβ), which is a 
potential cause of Alzheimer's disease as it has been 
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shown to mediate neurodegenerative alterations that 
are associated with amyloid plaques (Malinin et al., 
2005; Harold et al., 2007). 
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